Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
Cancer Treatment May Result In Bone Loss
http://www.medicalnewstoday.com/articles/129429.php
<b>New cross-Canada study in <i>Journal of Clinical Oncology</i> outlines risks</b>A new cross-Canada study has found that breast and prostate cancer treatment can foster bone loss. In the online edition of the <i>Journal of Clinical Oncology</i>, the scientists explain how loss of bone mass might affect 46,000 people diagnosed with breast and prostate cancer each year* and place them at increased risk for osteoporosis and fractures.
----------------------------------------------
** CANCER / ONCOLOGY News **
Inflammatory Myofibroblastic Tumors Of The Genitourinary Tract--Single Entity Or Continuum?
http://www.medicalnewstoday.com/articles/129533.php
UroToday.com - Can we meaningfully separate inflammatory pseudotumor (a term used since 1937 1 from inflammatory myofibroblastic tumor (IMT, a term introduced in 1990 for lung lesions 2 and from sarcoma? The oldest large series of 38 such cases in the urinary bladder divided most of them into 17 pseudotumors and 13 sarcomas 3.
Cleveland Clinic Recognizes Circulating Tumor Cell Technology As Top Medical Innovation For 2009
http://www.medicalnewstoday.com/articles/129501.php
Veridex, LLC announced today that the technology used in the CellSearch® System to measure circulating tumor cells (CTCs) was ranked as the top medical innovation for 2009 by the <a href="http://my.
The Forgotten Cancer - European Patient Group Formed
http://www.medicalnewstoday.com/articles/129487.php
European advocacy and support groups working with patients whohave some of the rarest cancers have agreed to form a collaborativeassociation.Sarcoma Patients EuroNet (SPAEN) will start work in January2009 with the aim of extending information services, patient support andadvocacy so that patients across the whole of Europe can benefit.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
GARDASIL(R) Demonstrated Efficacy In Preventing HPV-Related Disease In Males In Phase III Study
http://www.medicalnewstoday.com/articles/129489.php
GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant], the cervical cancer vaccine from Merck & Co., Inc., prevented 90 percent of external genital lesions caused by human papillomavirus (HPV) types 6, 11, 16 and 18 in a pivotal Phase III study in men aged 16 to 26.
----------------------------------------------
** COLORECTAL CANCER News **
No news for this category today.
----------------------------------------------
** LUNG CANCER News **
No news for this category today.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
No news for this category today.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
New Findings Offer Fresh Hope To Men With Prostate Cancer That Has Returned After Attempted Cure
http://www.medicalnewstoday.com/articles/129549.php
The link between the PSA (prostate-specific antigen) blood test and the detection of prostate cancer is well-established. In new findings released publicly for the first time today, Australian and New Zealand researchers have demonstrated how two serial measures of PSA can be used to accurately predict a patient's prognosis when prostate cancer returns after attempted cure.
Treatment Of Patients After Failed High Intensity Focused Ultrasound And Radiotherapy For Localized Prostate Cancer
http://www.medicalnewstoday.com/articles/129532.php
UroToday.com - One of the international leaders in laparoscopic radical prostatectomy, Jens-Uwe Stozenburg from Leipzig, Germany and associates has reported on the use of salvage laparoscopic extra-peritoneal radical prostatectomy (EERPE) following failed high intensity focused ultrasound therapy (HIFU), external beam radiotherapy (ERBT) or brachytherapy.
Cancer Treatment May Result In Bone Loss
http://www.medicalnewstoday.com/articles/129429.php
<b>New cross-Canada study in <i>Journal of Clinical Oncology</i> outlines risks</b>A new cross-Canada study has found that breast and prostate cancer treatment can foster bone loss. In the online edition of the <i>Journal of Clinical Oncology</i>, the scientists explain how loss of bone mass might affect 46,000 people diagnosed with breast and prostate cancer each year* and place them at increased risk for osteoporosis and fractures.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment